Synapse - Works

Results (116624)

Clinical manufacture of FT819: Use of a clonal multiplexed-engineered master induced pluripotent stem cell line to mass produce off-the-shelf CAR T-cell therapy

Meeting Abstract

Yuan, X.; Clarke, R.; Lai, Y. S.; Chang, C. W.; Yang, B. H.; Hsia, G.; Abujarour, R.; Lee, T.; van der Stegen, S.; Shaked, H.; more...
Blood (2021)

Fulltext@MSK | Save

Clinical experience in the randomized phase 3 Sierra Trial: Anti-CD45 iodine ((131)I) apamistamab [Iomab-B] conditioning enables hematopoietic cell transplantation with successful engraftment and acceptable safety in patients with active, relapsed/refractory AML not responding to targeted therapies

Meeting Abstract

Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Koshy, N. V.; Stiff, P.; Abboud, C. Sr; Tomlinson, B.; Abhyankar, S.; more...
Blood (2021)

Fulltext@MSK | Save

SRSF2-P95H delays myelofibrosis development through altered JAK/STAT signaling in JAK2(V617F) megakaryocytes

Meeting Abstract

Willekens, C.; Laplane, L.; Dagher, T.; Benlabiod, C.; Lacout, C.; Rameau, P.; Catelain, C.; Alfaro, A.; Edmond, V.; Signolle, N.; more...
Blood (2021)

Fulltext@MSK | Save

Quantitative change in metabolic tumor volume may assist in distinguishing between pseudoprogressors and responders in patients with relapsed/refractory classical Hodgkin lymphoma treated with PD-1 blockade

Meeting Abstract

Wills, B.; Michaud, L.; Schöder, H.; Ganesan, N.; Moskowitz, C. H.; Straus, D. J.; Falchi, L.; Matasar, M. J.; Zelenetz, A. D.; Joffe, E.; more...
Blood (2021)

Fulltext@MSK | Save

Outcomes of aggressive B cell lymphoma patients with no evidence of measurable disease at the time of CD19 chimeric antigen receptor T cell therapy: The experience from the CAR T Cell Consortium

Meeting Abstract

Wudhikarn, K.; Tomas, A. A.; Brower, J.; Bachanova, V.; Maziarz, R. T.; McGuirk, J. P.; Nastoupil, L.; Porter, D. L.; Riedell, P. A.; Perales, M. A.
Blood (2021)

Fulltext@MSK | Save

Combination of three unique anti-tumor modalities engineered into iPSC-derived T cells demonstrate a synergistic effect in overcoming tumor heterogeneity and cancer escape

Meeting Abstract

Yang, B. H.; Lin, Y. S. E.; Shirinbak, S.; Yeh, W. I.; Pribadi, M.; Chu, H. Y.; Gutierrez, A.; Mehta, A.; Avramis, E.; Petrovic, R.; more...
Blood (2021)

Fulltext@MSK | Save

Single-cell profiling reveals clinically relevant evolutionary trajectories and alternate biologies in human follicular lymphoma

Meeting Abstract

Wang, X.; Nissen, M.; Gracias, D.; Kusakabe, M.; Simkin, G.; Duns, G.; Sarkozy, C.; Chavez, E.; Segat, G. C.; Kim, J.; more...
Blood (2021)

Fulltext@MSK | Save

Impact of platelet transfusion on pulmonary function of hematology oncology patients: The Piper study

Meeting Abstract

Wheeler, A. P.; Snyder, E. L.; Refaai, M. A.; Cohn, C. S.; Poisson, J.; Fontaine, M. J.; Sehl, M.; Nooka, A. K.; Uhl, L.; Spinella, P. C.; more...
Blood (2021)

Fulltext@MSK | Save

Metabolic tumor volume and total lesion glycolysis can predict response to very low dose radiotherapy (4 Gy) in indolent B-cell lymphomas

Meeting Abstract

Wijetunga, N. A.; Imber, B. S.; Lee, J.; Hajj, C.; Mayerhoefer, M. E.; Schoder, H.; Yahalom, J.
Blood (2021)

Fulltext@MSK | Save

Efficacy and safety of extended use of romiplostim treatment for chemotherapy-induced thrombocytopenia

Meeting Abstract

Wilkins, C. R.; Ortiz, J.; Gilbert, L.; Yin, S.; Mones, J. V.; Parameswaran, R.; Mantha, S.; Soff, G. A.
Blood (2021)

Fulltext@MSK | Save